Wang Lei, Lu XueRong, Szalad Alexandra, Liu Xian Shuang, Zhang Yi, Wang Xinli, Golembieski William Anthony, Powell Brianna, Mccann Mikkala, Lu Mei, Chopp Michael, Zhang Zheng Gang
Department of Neurology, Henry Ford Hospital, Detroit, MI, United States.
Department of Biostatistics and Research Epidemiology, Henry Ford Hospital, Detroit, MI, United States.
Front Cell Neurosci. 2024 Sep 2;18:1462228. doi: 10.3389/fncel.2024.1462228. eCollection 2024.
MicroRNAs (miRNAs) in Schwann cells (SCs) mediate peripheral nerve function. Ablating Dicer, a key gene in miRNA biogenesis, in SCs causes peripheral neuropathy. Exosomes from healthy SCs (SC-Exo) ameliorate diabetic peripheral neuropathy in part via miRNAs. Thus, using transgenic mice with conditional and inducible ablation of Dicer in proteolipid protein (PLP) expressing SCs (PLP-cKO), we examined whether SC-Exo could reduce peripheral neuropathy in PLP-cKO mice.
PLP-cKO mice at the age of 16 weeks (8 week post-Tamoxifen) were randomly treated with SC-Exo or saline weekly for 8 weeks. Age-and sex-matched wild-type (WT) littermates were used as controls. Peripheral neurological functions, sciatic nerve integrity, and myelination were analyzed. Quantitative RT-PCR and Western blot analyses were performed to examine miRNA and protein expression in sciatic nerve tissues, respectively.
Compared to the WT mice, PLP-cKO mice exhibited a significant decrease in motor and sensory conduction velocities, thermal sensitivity, and motor coordination. PLP-cKO mice exhibited substantial demyelination and axonal damage of the sciatic nerve. Treatment of PLP-cKO mice with SC-Exo significantly ameliorated the peripheral neuropathy and sciatic nerve damage. PLP-cKO mice showed a substantial reduction in a set of Dicer-related miRNAs known to regulate myelination, axonal integrity, and inflammation such as miR-138, -146a and - 338 in the sciatic nerve. In addition, PLP-cKO mice exhibited significant reduction of myelin forming proteins, early growth response 2 (EGR2) and sex determining region Y-box10 (Sox10), but significantly increased myelination inhibitors, Notch1, c-Jun, and Sox2 and the axonal growth inhibitor phosphatase and tens in homolog (PTEN). However, SC-Exo treatment reversed the PLP-cKO altered miRNAs and proteins.
This study demonstrates that exogenous SC-Exo ameliorate peripheral neuropathy induced by Dicer ablation in PLP expressing SCs. The therapeutic benefit may be mediated by the SC-Exo altered miRNAs and their targeted genes.
雪旺细胞(SCs)中的微小RNA(miRNAs)介导周围神经功能。在雪旺细胞中敲除Dicer(miRNA生物发生中的关键基因)会导致周围神经病变。来自健康雪旺细胞的外泌体(SC-Exo)部分通过miRNAs改善糖尿病周围神经病变。因此,我们使用在表达蛋白脂蛋白(PLP)的雪旺细胞中有条件且可诱导敲除Dicer的转基因小鼠(PLP-cKO),研究SC-Exo是否能减轻PLP-cKO小鼠的周围神经病变。
16周龄(他莫昔芬给药后8周)的PLP-cKO小鼠每周随机接受SC-Exo或生理盐水治疗,持续8周。将年龄和性别匹配的野生型(WT)同窝小鼠作为对照。分析周围神经功能、坐骨神经完整性和髓鞘形成。分别进行定量RT-PCR和蛋白质免疫印迹分析,以检测坐骨神经组织中的miRNA和蛋白质表达。
与WT小鼠相比,PLP-cKO小鼠的运动和感觉传导速度、热敏感性及运动协调性显著降低。PLP-cKO小鼠表现出坐骨神经明显的脱髓鞘和轴突损伤。用SC-Exo治疗PLP-cKO小鼠可显著改善周围神经病变和坐骨神经损伤。PLP-cKO小鼠坐骨神经中一组已知可调节髓鞘形成、轴突完整性和炎症的与Dicer相关的miRNAs,如miR-138、-146a和-338,显著减少。此外,PLP-cKO小鼠的髓鞘形成蛋白、早期生长反应2(EGR2)和性别决定区Y框10(Sox10)显著减少,但髓鞘形成抑制剂Notch1、c-Jun和Sox2以及轴突生长抑制剂磷酸酶和张力蛋白同源物(PTEN)显著增加。然而,SC-Exo治疗逆转了PLP-cKO小鼠中miRNAs和蛋白质的改变。
本研究表明,外源性SC-Exo可改善PLP表达的雪旺细胞中Dicer缺失诱导的周围神经病变。其治疗益处可能由SC-Exo改变的miRNAs及其靶向基因介导。